The current limitations of molecular diagnostics, such as PCR, do not allow for rapid screening and personalized follow-up of cancers and viral diseases. Healthcare professionals and institutions are therefore looking for simple, rapid and cost-effective tests for screening and monitoring patients. BrightSens Diagnostics will provide the solution to these needs by offering highly sensitive Point of Care tests. Our patented technology, with unique properties, is the result of 10 years of research supported by 2 ERC contracts with over 2M Euros. Our ultra-bright and ultra-sensitive fluorescent NanoAntennas amplify a detection signal. They allow direct measurement of very low concentrations of RNA - disease biomarkers - without enzymes, by simple fluorescence measurement. Our Point of Care tests will revolutionize molecular diagnostics.
| Website | https://brightsens-diag.com/ |
| Employees | 6 (3 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Medical Diagnostics, Molecular Diagnostics, Rapid Diagnostics, Healthcare Diagnostics, Diagnostic Testing, Cancer Diagnostics, Viral Diagnostics, Clinical Diagnostics, Personalized Medicine, Disease Diagnostics, Biomedical Diagnostics, Point Of Care Diagnostics, Affordable Diagnostics, Cost Effective Diagnostics, Screenings |
| Competitors | Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, BD, Ortho Clinical Diagnostics - ANZ, Hologic, Inc., Bio-Rad Laboratories, Cepheid, GenMark Diagnostics +31 more (view full list) |
Looking for a particular BrightSens Diagnostics employee's phone or email?
BrightSens Diagnostics Questions
3 people are employed at BrightSens Diagnostics.
Top BrightSens Diagnostics Employees
